Prévisions

Aucune donnée d'analyste n'est disponible pour cette entreprise.

Actualités Accéder au fil d'actualités

Freenome hits record high of $14.48

Freenome’s stock climbed to a record high of $14.48, bringing the company’s market capitalization to about $1.5 billion. Over the past year the share price rose 35.27% and currently trades above InvestingPro’s fair-value estimate. TD Cowen, BTIG and Jefferies initiated coverage with buy ratings and $17.00 price targets, highlighting Freenome’s potential in blood-based cancer screening tests and partnerships with Abbott and Roper. Investors should weigh the strong price momentum against signs of possible overvaluation. » Plus sur de.investing.com